Covid-19 roundup: Eu­rope pur­chas­es 80M dos­es of Mod­er­na's vac­cine; CO­V­AXX se­cures $2.8B in emerg­ing mar­ket pre-or­ders

With the an­nounce­ment of its vac­cine ef­fi­ca­cy da­ta last week, Mod­er­na is start­ing to line up cus­tomers for its Covid-19 mR­NA jabs.

The Mass­a­chu­setts-based biotech an­nounced Wednes­day it has agreed to sell an ini­tial round of 80 mil­lion dos­es to the Eu­ro­pean Com­mis­sion, with the op­tion to dou­ble the amount to 160 mil­lion. Once the mem­ber states rub­ber stamp the ap­proval, the deal will be fi­nal­ized.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.